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Highly virulent community-acquired methicillin-resist-
ant  Staphylococcus aureus (CA-MRSA) with Panton-
Valentine leukocidin (PVL) is common worldwide. Using
antimicrobial drug susceptibility testing, staphylococcal
cassette chromosome mec typing, exotoxin profiling, and
pulsed-field gel electrophoresis typing, we provide evi-
dence that supports the relationship between nasal strains
of PVL-positive MRSA and community-acquired disease.
P
anton-Valentine leukocidin (PVL) is a 2-component
cytotoxin that targets human and rabbit polymor-
phonuclear cells, monocytes, and macrophages (1). Gene
products of PVL (lukS-PV and lukF-PV), which are
encoded by contiguously located, cotranscribed genes
(lukS-PV and lukF-PV), assemble as hetero-oligomers and
synergistically exert cytolytic pore-forming activity (1).
PVL is mainly associated with primary cutaneous infec-
tions, especially furuncles, and with severe necrotizing
community-acquired pneumonia (2). The PVL locus is
present in most community-acquired methicillin-resistant
Staphylococcus aureus (CA-MRSA) isolates studied and is
a stable marker of CA-MRSA strains worldwide (3).
In a previous study, we found that CA-MRSA skin and
soft tissue infections among Taiwanese children are caused
by a predominantly endemic strain that has PVL genes (4).
Nasal carriage of MRSA also plays a key role in the epi-
demiology and pathogenesis of community-associated dis-
ease (5). Therefore, our prospective investigation sought to
1) determine the prevalence of PVL-positive S.  aureus
among isolates from children with various staphylococcal
diseases and asymptomatic nasal colonization, and 2) test
the hypothesis that CA-MRSA infection is associated with
community PVL-positive MRSA nasal carriage.
The Study
The study protocol was reviewed and approved by the
National Defense Medical Center Institutional Review
Board. Two collections of S. aureus isolates were used. A
list of all children <14 years of age hospitalized with vari-
ous staphylococcal infections during the period from
December 2003 to November 2005 was compiled from
records at the clinical microbiology laboratory at the Tri-
Service General Hospital in Taipei. The first collection of
144 infecting strains was further categorized into 11 types
of staphylococcal infection on the basis of the clinical
details provided. A case was considered community
acquired if MRSAwas isolated from cultures of specimens
obtained within 72 hours after hospitalization. Risk factors
for MRSA infection included hospitalization <12 months
before the date of MRSA isolation; history of any surgical
procedure; history of endotracheal intubation; underlying
chronic disorder; antimicrobial drug therapy <12 months
before the date of MRSA isolation; presence of an
indwelling venous or urinary catheter; or household con-
tact with a person with an identified risk factor or a work-
er in a healthcare environment (6).
A second collection of 300 colonizing strains was
obtained during the same period by culturing samples from
the anterior nares of 1,195 healthy children in the commu-
nity. Eligible participants were <14 years of age with no
acute medical problem who either visited a healthcare
facility for a well-child checkup or attended 1 of 7 kinder-
gartens in Taipei.
MRSA identification and antimicrobial drug suscepti-
bility were determined according to the Clinical
Laboratory Standards Institute (formerly known as the
National Committee for Clinical Laboratory Standards)
guidelines (7,8). Staphylococcal cassette chromosome mec
(SCCmec) elements were typed and PVL genes were
detected as described (2,9,10). Sequences specific for sea
to see, seg to sei, eta, etb, and tst, which encode staphylo-
coccal enterotoxins (SEA to SEE, and SEG to SEI), exfo-
liative toxins (ETA and ETB), and toxic shock syndrome
toxin-1, respectively, were detected by using methods
described by Jarraud et al. (11). Pulsed-field gel elec-
trophoresis (PFGE) was performed by using a CHEF
Mapper XA system (Bio-Rad Laboratories, Hercules, CA,
USA) according to a published protocol (12).
Data were analyzed by the Mantel-Haenszel test and χ2
test with SPSS version 10.0 software (SPSS, Chicago, IL,
USA). A p value <0.05 was considered significant.
Of the 444 isolates examined, PVL-positive isolates
constituted 23% of all S.  aureus isolates analyzed
(Table 1). Among 144 isolates (67 methicillin-susceptible
S. aureus isolates and 77 MRSA isolates) from different
staphylococcal infections, 82 (56.9%) were PVL positive,
and most were associated with skin and soft tissue
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of Chinainfections (especially furuncles). In contrast, only 18 (6%)
of 300 colonizing isolates had the PVL locus. PVL genes
were also found in isolates associated with other deep-
space infections including pyomyositis, osteomyelitis, and
septic arthritis. Of 1,195 healthy children who were
screened, 89 (7.4%) had cultures with MRSA. Only 15
(16.9%) of 89 community MRSA-colonizing strains were
PVL positive.
Among the 144 S. aureus isolates obtained from vari-
ous types of staphylococcal disease, 32 (22.2%) isolates
were further confirmed as CA-MRSA according to the
inclusion criteria (abscess [n = 5], carbuncles [n = 6], cel-
lulitis [n = 9], furuncles [n = 3], pyomyositis [n = 1],
osteomyelitis [n = 1], pneumonia [n = 1], and staphylococ-
cal scarlet fever [n = 6]); all contained the genes encoding
PVL. Antibiograms of 15 PVL-positive MRSA-colonizing
strains did not differ significantly from those of 32 CA-
MRSA–infecting strains with respect to clindamycin,
erythromycin, gentamicin, and chloramphenicol. All 47
PVL-positive MRSAisolates were resistant to penicillin G,
and none had reduced susceptibility to vancomycin,
teicoplanin, trimethoprim-sulfamethoxazole, fusidic acid,
or ciprofloxacin.
To gain insight into the association between nasal
strains of PVL-positive MRSA and community-acquired
disease, we designed a comparative study in which the col-
onization and clinical samples were collected during the
same period. Results of SCCmec typing and exotoxin pro-
filing for both community MRSA-colonizing strains and
CA-MRSA–infecting strains are shown in Table 2. Of 74
colonizing strains that did not have the PVL locus, most
(94.6%) had SCCmec IV, and only 1 (1.35%) had SCCmec
VT. Conversely, irrespective of origin, PVL-positive
MRSA strains were more likely to have SCCmec VT than
were the PVL-negative MRSA-colonizing strains
(p<0.001). Regarding the exotoxin profiles, the most fre-
quently encoded toxin gene among PVL-positive MRSA
isolates was seb (97.9%). PVL-positive MRSA-colonizing
strains and CA-MRSA–infecting strains were more likely
to have genes that encoded SEB than were PVL-negative
CA-MRSA–colonizing strains (p = 0.006). Genes for
SEG/SEI were found only in PVL-negative MRSA-colo-
nizing strains (p<0.001).
Diverse pulsotypes were found among the 47 PVL-pos-
itive MRSA strains subjected to PFGE typing (Figure).
Two clusters that included 33 (70.2%) isolates were distin-
guished at the 70% similarity level. None of the isolates
were linked on review of epidemiologic data derived from
medical records. Except for 1 colonizing isolate (C7) and
2 infecting isolates (I22 and I23) that carried SCCmec IV,
the other 30 (90.9%) isolates from clusters I and II had
SCCmec VT.
Conclusions
This is the first epidemiologic study of PVL-positive S.
aureus in Taiwan. The prevalence of PVL-positive S.
aureus among isolates collected from various types of
staphylococcal infections was 56.9%; previous surveys
reported rates of <5% to 12.4% (13–15). This higher
prevalence is probably related to the greater proportion of
pediatric patients with cutaneous infections. The frequen-
cies of infections associated with these organisms were
similar to those in previous studies (2,13,14). Overall, the
outcomes of infections with PVL-positive strains were
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Only 1 death occurred.
Four factors that support the relationship between nasal
strains of PVL-positive MRSA and community-acquired
disease. First, both PVL-positive MRSA-colonizing
strains and CA-MRSA–infecting strains had consistent
antibiograms. Second, most PVL-positive MRSA-coloniz-
ing strains and CA-MRSA–infecting strains had SCCmec
VT, whereas a high prevalence of SCCmec IV was found
among PVL-negative MRSA-colonizing strains. Third,
PVL-positive MRSA-colonizing strains and CA-
MRSA–infecting strains had consistent exotoxin profiles,
which differed from those of PVL-negative MRSA-colo-
nizing strains. Fourth, PFGE findings indicate that some
Methicillin-resistant Staphylococcus aureus, Taiwan
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Figure. Pulsed-field gel electrophoresis patterns and phylogenetic
tree of 47 methicillin-resistant Staphylococcus aureus (MRSA) iso-
lates with Panton-Valentine leukocidin (PVL) genes. Banding pat-
terns were digitalized and analyzed with Molecular Analyst
Fingerprinting, Fingerprinting Plus, and Fingerprinting DST soft-
ware (Bio-Rad Laboratories, Hercules, CA, USA). The grouping
method was performed to deduce a dendrogram from the matrix
by the unweighted pair group method with arithmetic averages
clustering technique after calculation of similarities using the
Pearson correlation coefficient between each pair of organisms.
The scale indicates the level of pattern similarity. Similarities >70%
represent clonal spread of strains. The first letter of each isolate
designation indicates the type of the isolate as follows: I, commu-
nity-acquired MRSA-infecting isolates; C, PVL-positive MRSA-col-
onizing isolates.PVL-positive MRSA isolates that colonized children who
remained asymptomatic were clonally related to clinically
isolated CA-MRSA–infecting strains, especially those
with SCCmec VT, compared with SCCmec IV (6/8, 75%
and 1/7, 14.3%, respectively).
Several study limitations merit consideration. First, our
study is a snapshot in time because the molecular epidemi-
ology of CA-MRSA is constantly changing. Second, we
were unable to determine risk for infection because chil-
dren colonized with community PVL-positive MRSAwere
not followed-up longitudinally. Finally, our results are geo-
graphically distinct and may not be generalized to the
global population.
Our study showed that PVLgenes are carried by a large
number of S. aureus isolates, especially among those caus-
ing disease. We provide evidence that links community
PVL-positive MRSA-colonizing strains to CA-
MRSA–infecting strains from various types of staphylo-
coccal infection.
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